Gene Query: RFX5

Dataset Description Geneva Score
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 61.0
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 40.92
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 35.92
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 28.74
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 27.88
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 27.85
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 27.33
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 27.33
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 27.07
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 27.0
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 25.87
RNA-seq differential expression studies: more sequence, or more replication? 21.02
Zika infected neural stem cells 20.82
Transcriptome analysis of Zika infected neural stem cells 20.82
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 20.73
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 20.04
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 19.83
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 19.83
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 19.45
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 19.21
Transcriptional responses of human insulinoma cells to acute cytokine exposure 19.02
Uridylation by TUT4 and TUT7 marks mRNA for degradation 18.53
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 18.12
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 18.12
Characterization of parental and rociletinib-resistant derived H1975 cell lines 18.06
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 17.99
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 17.94
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 17.47
Biological effect of chronic mistranslation in mammalian cells 17.47
Genome wide expression change in LCC2 and MCF-7 cells 16.96
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 16.62
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 16.37
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 16.12
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 16.05
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 15.9
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 15.64
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 15.48
Searching for target genes of miR-508/509/506/514 in HCT116 cells 15.14
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 15.07
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 14.97
ARID1A and ARID1B loss in HCT116 cells 14.9
Control of prostate tumour growth by the long non-coding RNA GHSROS 14.62
MeRIP-seq for heat shock in B-cell lymphoma cells 14.46
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 14.46
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 14.46
WRN knockout effects upon gene expression in SW48 and OVK18 14.43
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 14.43
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 14.41
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 14.27
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 14.24
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 14.24
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 14.19
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 14.16
Glioblastoma stem cells infected by ZIKA virus 13.75
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 13.6
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 13.6
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 13.57
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 13.48
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 13.35
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 13.19
Survival of pancreatic cancer cells lacking KRAS function 13.12
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 12.98
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 12.98
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 12.95
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 12.95
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 12.82
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 12.7
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 12.39
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 12.39
A practical evaluation of alignment algorithms for RNA variant calling analysis 12.26
Real-time observation of light-controlled transcription in living cells 12.11
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 12.07
Systematic discovery of endogenous human ribonucleoprotein complexes 11.79
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 11.68
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 11.59
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 11.5
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 11.48
NR2F2 study 11.38
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 11.38
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 11.34
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 11.33
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 11.33
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 11.28
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 11.19
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 11.12
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 11.02
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 10.98
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 10.97
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 10.92
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 10.92
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 10.73
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 10.67
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 10.66
RNA-seq of tumor cells following angiopellosis extravasation 10.39
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 10.34
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 10.24
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 10.24
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 10.14
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 10.14
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 10.11
Lipid degradation promotes prostate cancer cell survival 10.11
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 10.07
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 10.02
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 10.0
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 9.99
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 9.81
Mitochondrial dsRNA triggers antiviral signalling in humans 9.8
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 9.73
Patient-derived luminal breast cancer xenografts with progestins 9.72
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 9.72
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 9.68
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 9.68
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 9.66
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 9.66
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 9.66
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 9.59
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 9.48
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 9.48
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 9.45
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 9.41
Effect of Influenza virus infection on lncRNA expression in A549 cells 9.39
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 9.39
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 9.35
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 9.31
Gene Expression Profiling of SPOP Knocked Down Cell 9.2
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 9.19
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 9.19
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 9.19
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 9.16
A sister of NANOG regulates genes expressed in pre-implantation human development 9.1
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 9.1
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 9.05
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 9.05
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 9.05
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 9.03
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 9.03
Transcriptional profiling of LS1034 cells treated with tepoxalin 9.01
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 9.01
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 9.01
3’ Uridylation Expands miRNA Target Repertoire 8.94
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 8.9
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 8.9
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 8.87
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 8.86
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 8.81
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 8.74
LIN28A Over-expression RNAseq 8.73
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 8.69
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 8.69
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 8.69
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 8.63
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 8.6
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 8.59
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 8.59
Co-transcriptional loading of RNA export factors shapes the human transcriptome 8.59
RNAseq of HEK293 cells after Chtop knockdown 8.59
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 8.57
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 8.57
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 8.55
LNCaP treated with iBET 8.54
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 8.49
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 8.42
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 8.42
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.4
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 8.38
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 8.37
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 8.34
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 8.31
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 8.31
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 8.21
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 8.14
Gene expression changes associated with resistance to tagraxofusp (SL-401) 8.11
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 8.01
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.01
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 8.0
Functional role of SLIT2 and ROBO1 in trophoblasts 7.99
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 7.97
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 7.97
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 7.97
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 7.97
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 7.93
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 7.9
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 7.85
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 7.85
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 7.84
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 7.84
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 7.84
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 7.77
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 7.76
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 7.76
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 7.75
Transcriptome analysis of U87 cells upon LINC00152 knockdown 7.74
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 7.73
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 7.71
Ebola virus (EBOV) infection of ARPE-19 cells 7.68
The cohesin complex prevents Myc-induced replication stress 7.61
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 7.61
RNA-seq analyses of human prostate cancer cells 7.61
RNA sequencing of GlyH-101-treated MCF-7 cell line 7.6
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 7.58
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 7.56
RNA-seq analysis of BAP1-depleted uveal melanoma cells 7.48
RIG-I and MDA5 fRIP during KSHV lytic reactivation 7.46
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 7.45
EP400 is required for Max and MCPyV mediated gene activation 7.42
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 7.41
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 7.38
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 7.38
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 7.32
U1 snRNP telescripting regulates size-function stratified human genome 7.29
Transcriptional effect of ETV1 knockdown in melanoma cells 7.27
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 7.26
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 7.24
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 7.24
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 7.24
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 7.24
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 7.22
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 7.16
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 7.16
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 7.15
Short and Long RNA sequencing of human mature erythrocytes 7.12
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 7.12
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 7.09
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 7.09
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 7.08
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 7.07
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 7.07
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 7.05
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 7.03
RNA Seq of HMVEC under hypoxia 7.03
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 7.03
Gene expression analysis of the impact of TDP-43 knockout in human cells. 7.0
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.98
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  6.97
Gene induction by the USP6 oncogene in response to interferon 6.96
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 6.93
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 6.93
TGF-β promotes genomic instability after loss of RUNX3 6.9
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 6.89
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 6.89
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 6.89
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 6.77
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 6.75
Mapping interactions for the TNIP2 hub protein 6.72
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 6.69
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 6.68
IL-33 activates tumor stroma to promote intestinal polyposis 6.67
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 6.67
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 6.63
RNA-seq analyisis of PUM2 knockout cells 6.62
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 6.58
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 6.58
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 6.56
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 6.56
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 6.47
MYC dependent mRNA translation shapes gene expression and cell biology 6.47
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 6.46
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 6.46
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 6.45
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 6.44
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 6.44
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 6.42
Expression data from miR340 overexpressing human A549 cells 6.38
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 6.31
ARID1A regulates condensin II distribution and chromosomal partition 6.31
BASP1 modifies the Tamoxifen response 6.26
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 6.25
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 6.23
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 6.23
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 6.21
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 6.21
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 6.21
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 6.19
Total RNA-seq in ALL-SIL upon JQ1 inhibition 6.16
MARCKS and lnc-MARCKS act as inflammation regulators 6.15
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 6.14
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 6.14
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 6.13
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 6.13
Landscape and variation of RNA secondary structure across the human transcriptome 6.11
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 6.11
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 6.1
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 6.09
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 6.06
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 6.05
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 6.04
Effect of nuclear IL-33 on gene expression 6.0
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 5.96
Identification of Sin3B regulated genes during quiescence 5.92
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 5.9
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 5.86
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 5.85
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 5.84
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 5.75
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 5.75
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 5.63
AMPK signaling for naïve pluripotency [Hs] 5.63
AMPK signaling for naïve pluripotency 5.63
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 5.62
Chromatin-informed inference of transcriptional programs in gynecologic cancers 5.62
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.53
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.53
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 5.51
RNA expression analysis upon JMJD1C depletion 5.43
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 5.43
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 5.41
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 5.41
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 5.38
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 5.38
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 5.38
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 5.2
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 5.12
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 5.11
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 5.1
METTL3 and WTAP 5.07
Transcriptome landscape of HeLa response upon triamcinolone acetonide 5.05
IRF2 is a master regulator of human keratinocyte stem cell fate 5.02
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 5.02
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 5.01
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 5.0
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 5.0
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 4.97
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 4.93
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 4.73
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 4.73
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 4.72
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 4.67
Analysis of transcriptional regulation by Myt1 and Myt1l 4.64
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 4.59
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 4.56
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 4.52
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 4.48
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 4.48
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 4.45
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 4.41
Effects of rFVIIIFc on human macrophages 4.36
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 4.36
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 4.3
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 4.29
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 4.23
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 4.23
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 4.18
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 4.11
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 4.05
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 4.0
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.98
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 3.94
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 3.93
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 3.93
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.91
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 3.87
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 3.86
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 3.85
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 3.85
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 3.8
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 3.8
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 3.8
Genome-wide discovery of human splicing branchpoints 3.78
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 3.77
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 3.77
The effect of Abl kinases on non-small cell carcinoma global transcriptome 3.77
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 3.71
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 3.71
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 3.71
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 3.59
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 3.59
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 3.56
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 3.51
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 3.51
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 3.5
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 3.43
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 3.43
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 3.41
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 3.39
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 3.34
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 3.34
MCF-7 as a model for functional analysis of breast cancer risk variants 3.31
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.29
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 3.28
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 3.28
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 3.26
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 3.25
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 3.25
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 3.2
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 3.15
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 3.15
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 3.15
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 3.15
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 3.12
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 3.11
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 3.11
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 3.04
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 3.02
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 3.0
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 2.88
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 2.85
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 2.83
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 2.83
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 2.81
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 2.73
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 2.72
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 2.71
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 2.7
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 2.68
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 2.67
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 2.65
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.64
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 2.63
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.61
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 2.55
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 2.38
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 2.34
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 2.33
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 2.28
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.26
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.16
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 2.11
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 1.98
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 1.88
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.85
Macrophage Ad5f35 PhenoMap 1.84
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 1.82
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 1.79
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 1.79
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.79
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.71
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.71
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 1.69
Dermal endothelial cells of type 2 diabetic patients 1.68
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 1.66
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 1.51
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 1.45
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.43
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 1.4
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.4
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.4
Epigenomic conservation of transposable element silencing [RNA-seq] 1.38
Epigenomic conservation of transposable element silencing 1.38
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 1.32
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 1.3
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.27
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.27
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 1.23
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 1.23
Interphase condensins regulate ligand-depedent enhancer activation 1.22
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 1.22
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.21
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.17
Macrophage Ad5f35 M2 Challenge 1.16
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 1.09
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.03
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 1.03
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.93
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 0.92
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 0.86
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 0.86
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.84
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.84
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.84
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.77
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.72
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 0.68
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.67
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.64
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.64
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.64
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.63
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.55
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.54
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.5
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.5
Identification of long noncoding RNAs regulated by p53 0.49
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.49
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.43
6mer seed toxicity in viral microRNAs 0.4
siRNA-mediated knockdown 0.39
Active translatome profiling with RiboLace in MCF7 cells 0.37
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 0.32
Genome wide miR-191 target profile determined by RIP and gene expression profiling 0.32
Expression analysis of the TAF1 syndrome 0.27
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.25
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 0.24
Proteomics identifies a marker signature of MAPKi resistance in melanoma 0.23
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.21
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.21
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.16
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.16
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 0.1
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.09
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.08
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.08
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.08
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.08
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.07
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.07
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.07
The pioneer factor CEBPA modulates vitamin D signaling 0.07
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 0.02
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 0.02
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation